Haematologic Technologies Announces John Strokis as Vice President, Quality

ESSEX JUNCTION, Vt.: ESSEX JUNCTION, Vt., Dec. 16, 2021 /PRNewswire/ -- Haematologic Technologies ("HT"), a global leader in large molecule bioanalysis and biologic reagents, today announced the appointment of John Strokis as Vice President, Quality. John will lead quality initiatives through the next phase of the Company's growth, solidifying and...

Click to view original post